Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing…

Continue Reading
Pioneering Non-Invasive GI Diagnostics in the Era of Early Cancer Detection

Pioneering Non-Invasive GI Diagnostics in the Era of Early Cancer Detection

EQT Life Sciences’ recent $44 million Series B investment in Cyted Health marks a bold move…

Continue Reading
AI-powered blood test improves early Lyme disease detection

AI-powered blood test improves early Lyme disease detection

Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will…

Continue Reading
First Early Endometrial Cancer Detection Test Launched by Gnosis

First Early Endometrial Cancer Detection Test Launched by Gnosis

Credit: Mohammed Haneefa Nizamudeen / iStock / Getty Images Plus Gnosis recently launched EdenDx, the first…

Continue Reading
FDA approves first-ever blood test for Alzheimer’s detection

FDA approves first-ever blood test for Alzheimer’s detection

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and…

Continue Reading